FDA Inspection 1077818 — Epic Pharma, LLC

Epic Pharma, LLC — FEI 2431929

The FDA completed an inspection of Epic Pharma, LLC on February 1, 2019 in Laurelton, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 1, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Laurelton, NY (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
178721 CFR 211.80(a)Procedures To Be in Writing
2129521 CFR 211.110(b)In-process conformity - examination, sample testing
358521 CFR 211.110(a)Control procedures to monitor and validate performance
434221 CFR 211.142(b)Storage under appropriate conditions